Attached files

file filename
10-K/A - 10-K/A - GALECTIN THERAPEUTICS INCd188055d10ka.htm
EX-31.4 - EX-31.4 - GALECTIN THERAPEUTICS INCd188055dex314.htm
EX-10.50 - EX-10.50 - GALECTIN THERAPEUTICS INCd188055dex1050.htm

Exhibit 31.3

CERTIFICATIONS UNDER SECTION 302

I, Peter G. Traber, M.D., certify that:

 

  1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Galectin Therapeutics, Inc.; and

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: April 29, 2016

/s/ Peter G. Traber

Peter G. Traber, M.D.

President and Chief Executive Officer

(Principal Executive Officer)